| Literature DB >> 21088359 |
Abstract
We report herein the case of a 37-year-old man who developed probable progressive multifocal leukoencephalopathy (PML) following an umbilical cord blood transplant. The patient showed favorable clinical, neuroradiological and virological responses after treatment with mefloquine, an anti-malarial drug. Mefloquine may offer some benefits as a treatment for PML in patients with or without human immunodeficiency virus type-1 infection. This report highlights the need to gather sufficient data to confirm the efficacy of mefloquine against this devastating viral disease of the central nervous system.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21088359 DOI: 10.2169/internalmedicine.49.3227
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271